Our Technology

We have designed an assay that measures the expression of genes associated with intracranial aneurysm in circulating blood. This panel, formulated with our collaborators at DxTerity Diagnostics, uses quantitative polymerase chain reaction and capillary electrophoresis technology. The instruments used are widely available, allowing us to easily clinically integrate our test in the future.

AneuScreenTM for Brain Aneurysm Detection
AneuScreenTM for Brain Aneurysm Risk Profiling